The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia

Transplantation Proceedings

Volumn 42, Issue 3, 2010, Pages 890-894

  Kim, J M ^a   Kim, S J ^a   Joh, J W ^a   Shin, M ^a   Moon, J I ^a   Jung, G O ^a   Choi, G S ^a   Kwon, C H D ^a   Lee, S K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDEMIC DISEASE; FEMALE; HEPATITIS C; HUMAN; IMMUNOLOGY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDEMIC DISEASES; FEMALE; HEPATITIS C; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77955479782     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.041     Document Type: Conference Paper

References (10)

1. R.R. Razonable, and V.C. Emery Management of CMV infection and disease in transplant patients Herpes 11 2004 77
2. J.T. van der Meer, W.L. Drew, and R.A. Bowden Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection Antiviral Res 32 1996 119
3. R.R. Razonable, and C.V. Paya Infections and allograft rejection - intertwined complications of organ transplantation Swiss Med Wkly 135 2005 571
4. R.H. Rubin The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis' Curr Opin Infect Dis 20 2007 399
5. Cytomegalovirus Am J Transplant 4 Suppl 10 2004 51
6. D. Seehofer, N. Rayes, and U.P. Neumann Changing impact of cytomegalovirus in liver transplantation - a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis Transpl Int 18 2005 941
7. N. Rayes, D. Seehofer, and C.A. Schmidt Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation Transplantation 72 2001 881
8. E. Gane, F. Saliba, and G.J. Valdecasas Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients The Oral Ganciclovir International Transplantation Study Group [corrected] Lancet 350 1997 1729
9. C. Paya, A. Humar, and E. Dominguez Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients Am J Transplant 4 2004 611
10. N. Singh, C. Wannstedt, and L. Keyes Who among cytomegalovirus- seropositive liver transplant recipients is at risk for cytomegalovirus infection? Liver Transpl 11 2005 700